Suppression of mammary gland tumorigenesis in diabetic rats

COCCA C; GUTIÉRREZ A; NÚÑEZ M; CROCI M; G. MARTÍN; CRICCO G; RIVERA E; BERGOC R

CANCER DETECTION AND PREVENTION

ELSEVIER SCIENCE INC

Año: 2003

0361-090X

The aim of this study was to compare mammary gland tumorigenesis in diabetic and non-diabetic rats. Streptozotocin and N-nitroso-N-methylurea were used to induce diabetes and mammary tumors, respectively. A suppression of mammary carcinogenesis in diabetic rats was shown by a longer latency period, a lower number of tumors per animal and a smaller final tumor volume. An 84% of the lesions developed in diabetic animals were benign tumors. Eighty day-old diabetic rats had significantly lower plasma levels of total-IGF-I and insulin versus non-diabetic rats. We postulate that the decrease in the total IGF-I and insulin levels during the promotion phase of carcinogenesis in this model plays an important role in retarding the tumor development in diabetic animals and in favoring the development of benign mammary lesions.